In cancer, multiple studies have shown that BMP9 can mediate the maturation phase of angiogenesis and may contribute to blood vessel normalization through the inhibition of endothelial proliferation and migration, as well as the recruitment of pericytes (142, 146–148). This evidence concerns the gene GDF2 and cancer.